Skip to main content
BrainCited

Ginkgo biloba لـ Age-Related Cognitive Decline

C

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

الخلاصة

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

Key Study Findings

Review
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?
Dose: None مقابل: placebo Outcome: cognitive assessment scores (MMSE, SKT, NPI) التأثير: None None

المجتمع المدروس: patients with mild-to-moderate Alzheimer disease or vascular dementia

Review
Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: patients with vascular cognitive impairment and dementia

Review
The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Review of natural products for neuroprotection

Review
Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review.
Dose: None مقابل: None Outcome: Cognitive function in multiple sclerosis التأثير: None None

المجتمع المدروس: Multiple sclerosis patients (review)

Review
Nutritional strategies against dementia in rural populations.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: Rural populations with dementia risk

Cohort Study n=64 52 weeks Open-label
Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment.
Dose: 240 mg/day مقابل: Standard cognitive enhancers Outcome: Cognitive responder rate and AD conversion التأثير: 100% vs 59.1% responders; 0% vs 13.6% AD conversio <0.001 (responders); 0.037 (AD

المجتمع المدروس: Amyloid PET-positive MCI patients

Key Statistics

40

الدراسات

8000

المشاركون

Mixed

C

التقييم

Referenced Papers

Handbook of experimental … 2025 1 اقتباسات
Biomolecules 2021 161 اقتباسات
Pharmaceuticals (Basel, Switzerland) 2021 33 اقتباسات
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2020 4 اقتباسات
Acta bio-medica : … 2018 103 اقتباسات
Pharmacological research 2018 67 اقتباسات
Frontiers in nutrition 2018 18 اقتباسات
Journal of Alzheimer's … 2017 17 اقتباسات
Age (Dordrecht, Netherlands) 2014
Clinical pharmacokinetics 2013 220 اقتباسات
American family physician 2011
JAMA 2010 3 اقتباسات
The Practitioner 2010
The Cochrane database … 2009 299 اقتباسات
Epidemiologic reviews 2008 172 اقتباسات
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 اقتباسات
The Proceedings of … 2002 191 اقتباسات
The Cochrane database … 2002
Alternative medicine review … 1999 112 اقتباسات
Current opinion in … 1998 30 اقتباسات
British journal of … 1993 8 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

الحد الأعلى: 600 mg/day (doses above show no additional benefit)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
240 mg/day 52 weeks Positive 64
None -- Positive --
None -- Neutral --

أفضل وقت للتناول: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

التفاعلات المعروفة

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

الحد الأقصى المسموح به: 600 mg/day (doses above show no additional benefit)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Ginkgo biloba help with Age-Related Cognitive Decline?
Based on 40 studies with 8,000 participants, there is limited but promising evidence that Ginkgo biloba may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Ginkgo biloba should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 40 peer-reviewed studies with 8,000 total participants. The overall direction of effect is mixed.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.